NLM Publications / Upfront Immunotherapy at the Time of Metastatic Cancer Diagnosis Leads to Lower Brain Metastasis Velocity in Patient Undergoing Stereotactic Radiosurgery for Brain Metastases.
Upfront Immunotherapy at the Time of Metastatic Cancer Diagnosis Leads to Lower Brain Metastasis Velocity in Patient Undergoing Stereotactic Radiosurgery for Brain Metastases.